GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Return-on-Tangible-Equity

Surgical Innovations Group (LSE:SUN) Return-on-Tangible-Equity : -26.51% (As of Jun. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Surgical Innovations Group's annualized net income for the quarter that ended in Jun. 2024 was £-0.97 Mil. Surgical Innovations Group's average shareholder tangible equity for the quarter that ended in Jun. 2024 was £3.67 Mil. Therefore, Surgical Innovations Group's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 was -26.51%.

The historical rank and industry rank for Surgical Innovations Group's Return-on-Tangible-Equity or its related term are showing as below:

LSE:SUN' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -186.25   Med: -10.85   Max: 21.09
Current: -16.13

During the past 13 years, Surgical Innovations Group's highest Return-on-Tangible-Equity was 21.09%. The lowest was -186.25%. And the median was -10.85%.

LSE:SUN's Return-on-Tangible-Equity is ranked worse than
65.39% of 757 companies
in the Medical Devices & Instruments industry
Industry Median: 2.02 vs LSE:SUN: -16.13

Surgical Innovations Group Return-on-Tangible-Equity Historical Data

The historical data trend for Surgical Innovations Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Return-on-Tangible-Equity Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -59.45 -69.00 -9.74 5.86 -11.96

Surgical Innovations Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 12.39 -17.03 -6.60 -26.51

Competitive Comparison of Surgical Innovations Group's Return-on-Tangible-Equity

For the Medical Devices subindustry, Surgical Innovations Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Return-on-Tangible-Equity falls into.



Surgical Innovations Group Return-on-Tangible-Equity Calculation

Surgical Innovations Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.509/( (4.56+3.955 )/ 2 )
=-0.509/4.2575
=-11.96 %

Surgical Innovations Group's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-0.974/( (3.955+3.392)/ 2 )
=-0.974/3.6735
=-26.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Surgical Innovations Group  (LSE:SUN) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Surgical Innovations Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and equipment for precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment which derives key revenue, includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The Distribution segment includes the distribution of specialist medical products.